By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported that its fourth-quarter revenues declined 16 percent year over year, missing analysts' consensus estimate.

The Cincinnati-based diagnostics firm brought in total revenues of $35.5 million for the three months ended Sept. 30, compared to $42.5 million for the fourth quarter of 2009. It missed analysts' consensus estimate of $38.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.